Tag: United States
The Rise of Clitoral Enlargement Surgery: A Look at Women’s Expensive Choices
Women's Choices: The Rise of Clitoral Enlargement SurgeryAna, a medical assistant in Florida, made a life-changing decision in 2018. After learning about clitoral enlargement surgery, she decided to undergo the procedure to enhance her...
FDA Warns Sanofi of ‘Significant’ Issues at Key Manufacturing Plant – What You Need...
Breaking News: FDA Warns Sanofi of 'Significant' Manufacturing ProblemsIn a recent alarming development, the Food and Drug Administration (FDA) has issued a stern warning to pharmaceutical giant Sanofi regarding a multitude of "significant" manufacturing...
Next-Generation Chemotherapy Receives FDA Approval: What You Need to Know
Next-Generation Chemotherapy Receives FDA Approval: What You Need to KnowIn a groundbreaking development in the world of oncology, the FDA has granted approval for a cutting-edge antibody-drug conjugate aimed at revolutionizing breast cancer treatment....
Exploring the Benefits and Risks of GLP-1s: A Comprehensive Study
GLP-1 Drugs Unveiled: Promises and Pitfalls RevealedIn a groundbreaking study published in Nature Medicine on Monday, clinical epidemiologist and nephrologist Ziyad Al-Aly from Washington University in St. Louis unveiled the comprehensive benefits and risks...
Medicare to Negotiate Prices of Diabetes and Weight Loss Drugs
Medicare to Negotiate Prices of Diabetes and Weight Loss DrugsIn a groundbreaking move, Medicare officials have announced plans to negotiate the prices of two widely-used drugs for diabetes and weight loss. Ozempic and Wegovy,...
Walgreens Accused of Illegally Filling Millions of Opioid Prescriptions
Walgreens Faces Allegations of Illegally Dispensing Opioid PrescriptionsAfter years of meticulous investigation, the U.S. Department of Justice has taken a significant step by filing a civil lawsuit against Walgreens. The pharmacy giant stands accused...
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has stirred a heated debate among policymakers and healthcare experts. The...
Telehealth Rules for Adderall, Buprenorphine, and Controlled Meds: DEA Guidelines
DEA Introduces New Telehealth Rules for Controlled SubstancesThe Drug Enforcement Administration (DEA) has finally unveiled a long-awaited announcement regarding the prescription of controlled substances through telemedicine. This groundbreaking move comes after a 16-year delay...
Federal Court Ruling Benefits Nursing Home Residents with Disabilities: Q&A
Federal Court Ruling Benefits Nursing Home Residents with Disabilities: Q&AOver the past three decades, a significant shift in health policy has emerged, focusing on enabling individuals with disabilities to live and receive care in...
Patrizia Cavazzoni Departs FDA’s Drug Center: What it Means for the Agency
Patrizia Cavazzoni’s Departure and Its Implications for the FDAPatrizia Cavazzoni, the esteemed leader of the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER), has announced her departure from the agency on...
Importance of Surveillance in Public Health and National Security: Monitoring Emerging Disease Threats
Importance of Surveillance in Public Health and National Security: Monitoring Emerging Disease ThreatsThe recent advancement of the H5N1 bird flu serves as a stark reminder that novel pathogens continue to pose a...
Increasing Incentives for Meth Reduction Under Biden Administration: What You Need to Know
**Increasing Incentives for Meth Reduction Under Biden Administration: A Game-Changer in Addiction Treatment**In a groundbreaking move, the Biden administration has paved the way for a significant shift in addiction treatment by eliminating a major...
